Bacterial News and Research

RSS

Moderna vaccine reduces viral spread by at least 60 percent, finds study

An interesting new study by researchers at Harvard T.H. Chan School of Public Health in the U.S. suggests that the currently used Moderna vaccine reduces viral shedding by about 60%.

2 Mar 2021

Researchers explore early stages of ribosome formation to identify new targets for antibiotics

Ribosome formation is viewed as a promising potential target for new antibacterial agents. Researchers from Charité - Universitätsmedizin Berlin have gained new insights into this multifaceted process.

2 Mar 2021

New vaccination strategy could eliminate the bacteria that cause UTIs

Anyone who has ever developed a urinary tract infection (UTI) knows that it can be painful, pesky and persistent. UTIs have a high recurrence rate and primarily afflict women -- as many as 50% of women will experience at least one UTI during their lifetime.

1 Mar 2021

Commonly used sweeteners may promote antibiotic resistance

Researchers in Australia have conducted a study showing that commonly used nonnutritive sweeteners can promote the spread of antibiotic-resistant genes in the intestine.

28 Feb 2021

Bacteria use slimy strategy to defeat antibiotics that fight cystic fibrosis

University of Montana researchers and their partners have discovered a slimy strategy used by bacteria to defeat antibiotics and other drugs used to combat infections afflicting people with cystic fibrosis. The research was published Feb. 23 in the journal Cell Reports.

27 Feb 2021

Repurposed drugs show antiviral SARS-CoV-2 E channel blocking activity, finds study

A new study by researchers at The Hebrew University of Jerusalem in Israel reports the discovery of a promising group of E channel inhibitors with significant antiviral activity. This could be developed into new treatment agents for this often-deadly virus.

26 Feb 2021

Researchers use Doppler to look inside living cells, track their metabolic activity

Doppler radar improves lives by peeking inside air masses to predict the weather. A Purdue University team is using similar technology to look inside living cells, introducing a method to detect pathogens and treat infections in ways that scientists never have before.

26 Feb 2021

New test can detect viral infections in uncultured bacteria

The pandemic has made clear the threat that some viruses pose to people. But viruses can also infect life-sustaining bacteria and a Johns Hopkins University-led team has developed a test to determine if bacteria are sick, similar to the one used to test humans for COVID-19.

26 Feb 2021

Microbes could predict fatal outcomes in ventilated COVID-19 patients

The study "Microbial signatures in the lower airways of mechanically ventilated COVID19 patients associated with poor clinical outcome" is available as a preprint on the medRxiv* server, while the article undergoes peer review.

25 Feb 2021

Study of children hospitalized with COVID-19 shows 2% mortality

The COVID-19 pandemic caused by SARS-CoV-2 has been observed to be less serious in infants and children. However, this age group is also subject to certain complications following infection. A new study describes the findings of an observational study of children hospitalized with SARS-CoV-2 infection in several different hospitals across three countries.

25 Feb 2021

New vaccine, enhanced surveillance needed to combat childhood pneumonia

A rise in vaccine-resistant bacteria shows the need for a new vaccine to fight childhood empyema after a spike in hospitalisations, a new UNSW study reveals.

25 Feb 2021

Study reveals key mechanism by which exercise promotes immunity, strengthens bones

Scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) have identified the specialized environment, known as a niche, in the bone marrow where new bone and immune cells are produced.

25 Feb 2021

Travelers to the tropics are more prone to acquiring superbacteria than previously thought

Exploring exposure to superbacteria, researchers at the University of Helsinki and Helsinki University Hospital got unexpected results from an international collaborative study conducted in real time among 20 travelers to Southeast Asia.

24 Feb 2021

Hyperactive immune system contributes to COVID-19 severity, lung damage

Researchers have pinpointed a helper T cell population in the lungs of patients with severe COVID-19 that may be central to the development of hyperinflammation, lung injury, and subsequent acute respiratory distress syndrome (ARDS) during disease.

24 Feb 2021

International travelers are vulnerable to virulent strains of drug-resistant bacteria

International travelers are particularly vulnerable to virulent strains of drug-resistant bacteria - often picking up several different types during a trip through spending time in the company of other tourists, a new study reveals.

24 Feb 2021

Study: Interbacterial toxins may contribute to bacterial genetic diversity

A toxin produced by bacteria as a defence mechanism causes mutations in target bacteria that could help them survive, according to a study published today in eLife.

23 Feb 2021

Beneficial bacteria passed on to infants through breast milk change over time

The cocktail of beneficial bacteria passed from mother to infant through breast milk changes significantly over time and could act like a daily booster shot for infant immunity and metabolism.

23 Feb 2021

‘Resuscitating’ old antibiotics to combat the growing threat of superbugs

Holding off the rise of superbugs could be achieved by 'resuscitating' old antibiotics, with The University of Queensland researchers leading an international project to help combat the growing threat.

23 Feb 2021

'Phage therapy' helps treat mice infected with multidrug-resistant Klebsiella pneumoniae

Using viruses instead of antibiotics to tame troublesome drug-resistant bacteria is a promising strategy, known as bacteriophage or "phage therapy."

23 Feb 2021

Universal strain of bacteria derived from healthy human skin can treat eczema

In a new study out of University of California San Diego School of Medicine, researchers have identified a universal strain of bacteria derived from healthy human skin that can treat the most common type of eczema, also known as atopic dermatitis.

23 Feb 2021

Bacterial News and Research

Moderna vaccine reduces viral spread by at least 60 percent, finds study

Researchers explore early stages of ribosome formation to identify new targets for antibiotics

New vaccination strategy could eliminate the bacteria that cause UTIs

Commonly used sweeteners may promote antibiotic resistance

Bacteria use slimy strategy to defeat antibiotics that fight cystic fibrosis

Repurposed drugs show antiviral SARS-CoV-2 E channel blocking activity, finds study

Researchers use Doppler to look inside living cells, track their metabolic activity

New test can detect viral infections in uncultured bacteria

Microbes could predict fatal outcomes in ventilated COVID-19 patients

Study of children hospitalized with COVID-19 shows 2% mortality

New vaccine, enhanced surveillance needed to combat childhood pneumonia

Study reveals key mechanism by which exercise promotes immunity, strengthens bones

Travelers to the tropics are more prone to acquiring superbacteria than previously thought

Hyperactive immune system contributes to COVID-19 severity, lung damage

International travelers are vulnerable to virulent strains of drug-resistant bacteria

Study: Interbacterial toxins may contribute to bacterial genetic diversity

Beneficial bacteria passed on to infants through breast milk change over time

‘Resuscitating’ old antibiotics to combat the growing threat of superbugs

'Phage therapy' helps treat mice infected with multidrug-resistant Klebsiella pneumoniae

Universal strain of bacteria derived from healthy human skin can treat eczema

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News